相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice
Padma Kadiyala et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Michael Platten et al.
NATURE (2021)
Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas
Mirco Friedrich et al.
NATURE CANCER (2021)
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
Katrin Aslan et al.
NATURE COMMUNICATIONS (2020)
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
Ekaterina Friebel et al.
CELL (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types
Riyue Bao et al.
GENOME MEDICINE (2020)
Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients
Bas Weenink et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Predicting HLA class II antigen presentation through integrated deep learning
Binbin Chen et al.
NATURE BIOTECHNOLOGY (2019)
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Julien Racle et al.
NATURE BIOTECHNOLOGY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells
Lingjun Zhang et al.
CLINICAL CANCER RESEARCH (2018)
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse et al.
NATURE MEDICINE (2018)
D-2-hydroxyglutarate interferes with HIF-1 stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization
Martin Boettcher et al.
ONCOIMMUNOLOGY (2018)
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
Diana Miao et al.
NATURE GENETICS (2018)
The immune system profoundly restricts intratumor genetic heterogeneity
Idan Milo et al.
SCIENCE IMMUNOLOGY (2018)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomase
Gary Kohanbash et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Cancer immunotherapy: exploiting neoepitopes
Michael Platten et al.
CELL RESEARCH (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
Serena Pellegatta et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
分享论文
